Genomma Lab reports Q2 growth and Genomma Lab stock costs EUR 0.63

Published on 10/09/2026 at 16:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter results are due October 21, 2026 after the BMV close. Genomma Lab stock costs EUR 0.63 on October 9, 2026, unchanged.

Key points in brief

Genomma Lab has scheduled its third-quarter 2026 results for October 21, 2026.
Second-quarter revenue reached MXN 4,397.04 million, up 4.93 percent year over year.
Net income was MXN 374.49 million, down 24.29 percent from the previous quarter.
Genomma Lab stock was unchanged at EUR 0.63 at Lang & Schwarz on October 9, 2026.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab stock (ISIN MX01LA010006) was unchanged at EUR 0.63 at Lang & Schwarz on October 9, 2026 at 4:05 p.m. CEST. The company had scheduled its third-quarter 2026 results for October 21, 2026 after the Mexican Stock Exchange close, according to Morningstar on October 1, 2026.

Revenue grew in the second quarter

Genomma Lab reported revenue of MXN 4,397.04 million in the second quarter of 2026, an increase of 4.93 percent from the year-earlier period, according to Finanztrends. The same quarter produced net income of MXN 374.49 million, giving investors a larger contrast between sales growth and bottom-line performance.

What does Q2 revenue mean for margins?

Net income fell 24.29 percent from MXN 494.65 million in the previous quarter to MXN 374.49 million in the second quarter of 2026, while revenue increased from MXN 4,190.62 million to MXN 4,397.04 million, according to Investing.com. That combination puts profitability ahead of revenue growth as the central question for the October reporting date.

Three dated milestones shape the calendar

On July 22, 2026, Genomma Lab published its second-quarter earnings release, with revenue of MXN 4,397.04 million, according to Genomma Lab. On September 17, 2026, it announced Investor Day 2026. On October 1, 2026, the company announced the October 21 results date through Morningstar.

Two October dates matter

The next reporting date is October 21, 2026 after the BMV close, followed by the earnings conference call on October 22, 2026 at 11:00 a.m. Mexico City time, both dates reported by Morningstar. The company develops and markets over-the-counter pharmaceutical and personal care products, including brands for skincare, pain management and cold remedies.

Stock holds at EUR 0.63

Genomma Lab stock was trading at EUR 0.63 at Lang & Schwarz on October 9, 2026 at 4:05 p.m. CEST, unchanged versus the Lang & Schwarz prior close of EUR 0.63. The company had a USD 713.4 million market capitalization as of October 8, 2026, while its primary listing is on the Mexican Stock Exchange under ticker LABB. The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.